A downtrend has been apparent in Zura Bio Limited (ZURA) lately with too much selling pressure. The stock has declined 35.6% over the past four weeks. However, given the fact that it is now in ...

In other Zura Bio news, Director Parvinder Thiara sold 1,001,633 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $2.73, for a ...

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia ...

HENDERSON, Nev., February 24, 2025--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for ...